Literature DB >> 371800

The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.

A Deisseroth, R A Abrams.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 371800

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  8 in total

1.  Clinical pharmacokinetics of high-dose mitomycin C.

Authors:  R B Schilcher; J D Young; V Ratanatharathorn; C Karanes; L H Baker
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 2.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

Review 3.  High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.

Authors:  C F LeMaistre; W A Knight
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Cryoprotection of human bone marrow committed stem cells (CFU-c) by dextran, glycerol and dimethyl sulfoxide.

Authors:  R Odavic; J Blom; E A Beck; U Bucher
Journal:  Experientia       Date:  1980-09-15

5.  Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs.

Authors:  R A Abrams; K McCormack; C Bowles; A B Deisseroth
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

6.  Circulating hematopoietic progenitors in patients with primary lung cancer.

Authors:  E Shimizu; J N Mukai; Y Takaue; T Ogura
Journal:  Jpn J Cancer Res       Date:  1990-12

7.  Cancer therapy: reimbursement of new therapeutic technologies.

Authors:  H M Williams
Journal:  Yale J Biol Med       Date:  1992 Mar-Apr

8.  Bone marrow transplantation: current results in leukemia.

Authors:  G W Santos
Journal:  Yale J Biol Med       Date:  1982 Sep-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.